Commission Regulation amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, etofenprox, fenpropidin, flupyradifurone, hexythiazox, imazalil, spinosad and tebufenozide in or on certain products
The Commission adopted an implementing measure. Parliament can object; an adopted objection stops the measure.
Where it stands: Parliament adopted the objection on 16 September 2026 — the Commission measure is blocked.
- ✓ Referred to committee 16 September 2026
- ✓ Committee work
- ✓ Tabled for plenary
- ✓ Plenary vote Adopted 16 September 2026
- ✓ Parliament’s position Final
How a file moves through Parliament
A file is referred to one lead committee (others may give an opinion). Its rapporteur writes a draft report, committee members table amendments, and the committee votes to adopt the report. The report is then tabled for all MEPs; political groups can table further amendments, which are voted on before the final vote in plenary. The adopted resolution is Parliament’s final position; it is not itself law.
Who is working on it
- Lead committee
- ENVI — Environment, Climate and Food Safety
- Rapporteurs
- Christophe CLERGEAU S&DMartin HOJSÍK RenewJutta PAULUS Verts/ALEAnja HAZEKAMP The Left
The rapporteur drafts and negotiates the text for the lead committee; each other political group names a shadow rapporteur to follow the file.
The text, version by version
Newest version first. Open a version to read it in full. “What changed” shows the differences paragraph by paragraph; ✦ lines are AI-written from the texts themselves.
Timeline
- Committee stage
- 16 September 2026 Referred to the ENVI (Environment, Climate and Food Safety) committee
The lead committee prepares Parliament’s report.
- Plenary stage
- 16 September 2026 Plenary voteAdopted Adopted by a clear majorityFor 383 Against 278 Abstained 9
Final vote on the motion for a resolution · 57% of votes cast in favour